Inappropriate activation of an immune signaling pathway during infection leaves the body vulnerable to sepsis

September 26, 2012
Some bacterial infections will give rise to immune failure in the form of sepsis, a condition that poses an especially serious mortality risk for hospital patients. Credit: iStockphoto.com/francisblack

The inflammatory response is a double-edged sword—it enables the body to mount a vigorous defense against infection, but can also inflict serious physiological damage if allowed to rampage uncontrolled. Patients experience the worst of both worlds when an infection gives way to sepsis. They undergo an initial strong inflammatory response that subsequently gives way to immunosuppression, wherein immune cells no longer respond to toxic molecules produced by bacteria.

"Sepsis is a major cause of mortality in intensive care units worldwide," says Subhra Biswas of the A*STAR Singapore Immunology Network, "but no reliable biomarkers or specific drug therapies are available." This may soon change, thanks to new insights from Biswas and his co-workers. They have revealed how a specific population of known as monocytes could exacerbate this condition.

"It is believed that these cells play a role in regulating both the inflammatory and immunosuppressive features of sepsis," explains Biswas. However, there is a variety of monocyte subtypes, each of which manifests a different collection of that might activate distinct downstream signaling pathways. For this study, Biswas and his co-workers focused on a receptor protein called CD16, which is predominantly expressed on a particular subtype of monocytes. In the blood of patients with sepsis, they found increased numbers of CD16-expressing monocytes.

In many infections, sepsis is mediated largely by signaling pathways activated by the Toll-like receptor 4 (TLR4) protein. Biswas and co-workers learned that CD16 activation regulates the effects of TLR4 signaling in monocytes in a manner that may enable sepsis to progress. They observed that stimulation of both CD16 and TLR4 in monocytes led to the increased expression of a number of genes that contribute to inflammation. However, CD16-mediated signals also led to the expression of molecules that inhibit signaling pathways responsible for the initial inflammatory stage of sepsis. "These results indicate the possibility that this pathway acts as a 'switch' to tip the function of monocytes over the course of inflammation," says Biswas.

Although CD16 monocytes seem to be important contributors to sepsis, Biswas points out that their role needs to be further clarified before considering their use as a focus for therapy. "Targeting these cells at the wrong phase of sepsis could lead to problems for patients," he says. Accordingly, he and his team will continue to chart the role of monocytes throughout sepsis in order to understand how progression might be thwarted.

Explore further: Molecular causes for life-threatening fungal infections in case of sepsis unravelled

More information: Shalova, I. N., Kajiji, T., Lim, J. Y., Gómez-Piña, V., Fernández-Ruíz, I., et al. CD16 regulates TRIF-dependent TLR4 response in human monocytes and their subsets. The Journal of Immunology 188, 3584–3593 (2012). www.jimmunol.org/content/early … /16/jimmunol.1100244

Related Stories

Molecular causes for life-threatening fungal infections in case of sepsis unravelled

July 27, 2012
(Medical Xpress) -- Pathogenic fungi cause infections with a high mortality rate in patients with weakened immune systems. At Karl Kuchler’s CD Laboratory at the MedUni Vienna, the molecular causes of the life-threatening ...

A boost in microRNA may protect against sepsis and other inflammatory diseases

May 24, 2012
Acute inflammatory diseases, such as sepsis, as well as chronic inflammatory diseases like diabetes and arthritis, develop as a result of sustained inflammation of the blood vessel wall. Researchers at Brigham and Women's ...

Metastatic breast cancer hitches a free ride from the immune system

February 10, 2012
Inflammatory breast cancer (IBC) is the most lethal form of breast cancer . It spreads easily through the lymphatic and blood vessels, forming metastasis which can lead to multi-organ failure. New research published in BioMed ...

Researchers find potential new way to fight sepsis

June 10, 2011
By digging a little deeper, researchers may have found a potential target for reversing the deadly blood infection sepsis.

Alcohol impairs the body's ability to fight off viral infection

September 30, 2011
Alcohol is known to worsen the effects of disease, resulting in longer recovery period after trauma, injury or burns. It is also known to impair the anti-viral immune response, especially in the liver, including response ...

Recommended for you

Exposure to pet and pest allergens during infancy linked to reduced asthma risk

September 19, 2017
Children exposed to high indoor levels of pet or pest allergens during infancy have a lower risk of developing asthma by 7 years of age, new research supported by the National Institutes of Health reveals. The findings, published ...

MicroRNA helps cancer evade immune system

September 18, 2017
The immune system automatically destroys dysfunctional cells such as cancer cells, but cancerous tumors often survive nonetheless. A new study by Salk scientists shows one method by which fast-growing tumors evade anti-tumor ...

'Exciting' discovery on path to develop new type of vaccine to treat global viruses

September 15, 2017
Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.

Regular exercise, stress can both make a big difference in lupus, study finds

September 13, 2017
Waking up in the morning with the joint pain, swelling and stiffness that accompanies lupus doesn't exactly inspire a workout.

New research shows asthma drug's effectiveness over usual care alone

September 13, 2017
A new study co-authored by the University of Plymouth and published in The Lancet shows how an asthma drug was more effective at improving a patient's asthma control compared with their usual care.

Study reveals new clues to how a successful HIV vaccine could work

September 12, 2017
Scientists at The Scripps Research Institute (TSRI) have made a discovery that could speed efforts to develop a successful HIV vaccine.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.